These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 14743205

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
    Yanada M, Yaoi T, Shimada J, Sakakura C, Nishimura M, Ito K, Terauchi K, Nishiyama K, Itoh K, Fushiki S.
    Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.
    Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO, Park JG.
    Oncogene; 2004 Sep 02; 23(40):6736-42. PubMed ID: 15273736
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C, Hasegawa K, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yazumi S, Yamagishi H, Okanoue T, Chiba T, Hagiwara A.
    Clin Cancer Res; 2005 Sep 15; 11(18):6479-88. PubMed ID: 16166423
    [Abstract] [Full Text] [Related]

  • 7. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y, Tong D, Lou G, Zhang Y, Geng J.
    Pathobiology; 2008 Sep 15; 75(4):244-51. PubMed ID: 18580070
    [Abstract] [Full Text] [Related]

  • 8. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C, Yin B, Lu Q, Zhou X, Hu J, Yang Y, Yu F, Yuan Y.
    Cancer Invest; 2007 Dec 15; 25(8):685-90. PubMed ID: 18058463
    [Abstract] [Full Text] [Related]

  • 9. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH, Kim YS, Park BK, Hougaard S, Kim SJ.
    Oncogene; 2001 Mar 08; 20(10):1235-45. PubMed ID: 11313868
    [Abstract] [Full Text] [Related]

  • 10. Frequent inactivation of RUNX3 in endometrial carcinoma.
    Yoshizaki T, Enomoto T, Fujita M, Ueda Y, Miyatake T, Fujiwara K, Miyake T, Kimura T, Yoshino K, Kimura T.
    Gynecol Oncol; 2008 Sep 08; 110(3):439-44. PubMed ID: 18572225
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic inactivation of the RUNX3 gene in lung cancer.
    Sato K, Tomizawa Y, Iijima H, Saito R, Ishizuka T, Nakajima T, Mori M.
    Oncol Rep; 2006 Jan 08; 15(1):129-35. PubMed ID: 16328045
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor.
    Guo WH, Weng LQ, Ito K, Chen LF, Nakanishi H, Tatematsu M, Ito Y.
    Oncogene; 2002 Nov 28; 21(54):8351-5. PubMed ID: 12447699
    [Abstract] [Full Text] [Related]

  • 13. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
    Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Ito Y, Chayama K, Yasui W.
    Pathobiology; 2004 Nov 15; 71(3):137-43. PubMed ID: 15051926
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.
    Goel A, Arnold CN, Tassone P, Chang DK, Niedzwiecki D, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR.
    Int J Cancer; 2004 Dec 10; 112(5):754-9. PubMed ID: 15386381
    [Abstract] [Full Text] [Related]

  • 20. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Mori Y, Ogawa R, Katada T, Harata K, Fujii Y.
    Oncol Rep; 2008 Mar 10; 19(3):713-9. PubMed ID: 18288406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.